(Q43648910)

25 November 2017

Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine (English)

1 reference

25 November 2017

0 references

0 references

3

B R Martin

1 reference

25 November 2017

A H Lichtman

1

1 reference

PubMed ID

11420084

25 November 2017

J Fisher

series ordinal

2

1 reference

PubMed ID

11420084

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Pharmacology, Biochemistry and Behavior

25 November 2017

1 reference

25 November 2017

69

1 reference

25 November 2017

181-188

1 reference

25 November 2017

1-2

1 reference

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

The effect of withdrawal from cannabis on pentylenetetrazol convulsive threshold in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

A new device for the rapid measurement of impaired motor function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Clonidine and the treatment of the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Clonidine in heroin withdrawal syndrome: a controlled study in India

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Abstinence symptoms following oral THC administration to humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Abstinence symptoms following smoked marijuana in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Clinical studies of cannabis tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

l-delta-9-trans-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Effects of clonidine on morphine withdrawal signs in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900514-7

7 January 2021

10.1016/S0091-3057(01)00514-7

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11420084